The Turkish population concludes that high plasma levels of sLOX-1, ox-LDL, LOX-1 K167N, and 3′UTR188CT are significantly associated with the risk of developing preeclampsia, proposing sLOX-1 as a therapeutic target for this condition in pregnant women. The gene discussed is OLR1; the disease is preeclampsia.